Moxibac XG is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of following organisms:

Aerobic Gram-positive microorganisms:

Corynebacterium species, Micrococcus luteus, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, Staphylococcus warneri, Streptococcus pneumoniae, Streptococcus viridans group.

Aerobic Gram-negative microorganisms: Acinetobacter iwoffii, Haemophilus influenzae, Haemophilus parainfluenzae.

Dosage & Administration

Instill 1 drop in the affected eye(s) 2 times daily for 7 days.


Prolonged use may result in overgrowth of non-susceptible organisms, including fungi like with other anti-infectives.


Special Populations
Use in Pregnancy:
Pregnancy Category C. Moxifloxacin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus as there are no adequate and well-documented studies in pregnant women.


Use in Lactating Mother:
Moxifloxacin has not been measured in human milk, although it can be presumed to be excreted in human milk. Caution should be exercised when Moxifloxacin is administered to a lactating mother.


Pediatric Use:
The safety and effectiveness of Moxifloxacin in infants below four months of age was not proven. However, several clinical studies show that the drug may be used safely in children even younger than one month of age.


Geriatric Use:
No overall differences in safety and effectiveness have been observed between elderly and younger patients.

Product Details

Related Products

Alcadin (Alcaftadine 0.25%)

Alcaftadine 0.25%

Benozol BR (Brinzolamide 1% & Brimonidine Tartrate 0.2%)

Brinzolamide 1% + Brimonidine Tartrate 0.2% Eye Drop

Ocustin (Bepotastine Besilatr 1.5%)

Brinzolamide 1% + Brimonidine Tartrate 0.2% Eye Drop

Optafenac (Nepafenac 0.1%)

Brinzolamide 1% + Brimonidine Tartrate 0.2% Eye Drop